Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19 (RYTHMO-COV)

University Hospital of Bordeaux

Status: Completed

Conditions: Arrhythmia; SARS-CoV-2 Infection

Treatments: Diagnostic Test: ECG data analysis; Biological: Biological check-up data collect; Drug: Treatment data collect; Other: Collection of clinical events of interest

Study type: Observational

Funder types: Other

Identifiers

NCT04937621

CHUBX 2020/18

Details and patient eligibility

About

Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several medications used have the potential to increase QT interval and eventually provoke torsades de pointe. The investigators therefore create a study that include all patients with SARS-CoV-2 infection having an electrocardiogram (ECG). The investigators evaluate the percentage of patients with ECG abnormalities, describe the abnormalities and evaluate the occurrence of syncope, ventricular arrhythmia and corrected QT (cQT) interval modification in patients receiving treatment.

Full description

In patients with SARS-CoV-2 infection, the investigators analyze baseline ECG as well as follow-up ECG. Patients followed by Bordeaux University Hospital for COVID-19 can be included. ECG are digitized in the computerized patient file (DxCARE) for further analysis.

Enrollment: 196 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over 18 years of both gender,
• Followed by Bordeaux University Hospital for SARS-CoV-2 infection with a cardiac monitoring or ECG realized.
• Non opposition expressed.

Exclusion criteria

• Minor,
• Inability to understand the study

Trial design

196 participants in 1 patient group

SARS-CoV-2 infection

Description:

This group includes patients prospectively included during their follow-up at the Bordeaux University Hospital for COVID-19, as well as retrospectively included patients whose follow-up for COVID-19 has been completed.

Treatment:

Drug: Treatment data collect

Diagnostic Test: ECG data analysis

Other: Collection of clinical events of interest

Biological: Biological check-up data collect